CLINICAL TRIALS PROFILE FOR DAYPRO
✉ Email this page to a colleague
All Clinical Trials for DAYPRO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00688961 ↗ | Effects of Omacor and Aspirin on Platelet Function | Completed | Sanford Research | Early Phase 1 | 2007-06-01 | Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can affect blood clotting by altering the function of the blood platelets. Aspirin can do the same. The purpose of this study is to determine the individual and combined effects of these two agents on platelet function using a whole blood method. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DAYPRO
Condition Name
Clinical Trial Locations for DAYPRO
Trials by Country
Clinical Trial Progress for DAYPRO
Clinical Trial Phase
Clinical Trial Sponsors for DAYPRO
Sponsor Name